E-LIB Suche - Ergebnisse für: Koenig, Andrew S.

1

Reduced Risk of Infections with the Intravenous Immunoglobu..:

Lahue, Betsy J ; Mallick, Rajiv ; Zhang, Xiang...
Immunotherapy. 14 (2022) 15 - p. 1245-1261 , 2022

2

Long‐term extension study of tofacitinib in refractory derm..:

Paik, Julie J. ; Shneyderman, Matthew ; Gutierrez‐Alamillo, Laura...
Arthritis & Rheumatology. 74 (2021) 2 - p. 371-372 , 2021

Link: https://doi.org/10.1002/..

3

The role of C-reactive protein as a predictor of treatment ..:

Baraliakos, Xenofon ; Szumski, Annette ; Koenig, Andrew S..
Seminars in Arthritis and Rheumatism. 48 (2019) 6 - p. 997-1004 , 2019

Link: https://doi.org/10.1016/..

4

Predictors of remission with etanercept-methotrexate induct..:

Smolen, Josef S. ; Szumski, Annette ; Koenig, Andrew S...
Arthritis Research & Therapy. 20 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

5

Clinical and demographic factors associated with change and..:

Reed, George W. ; Collier, David H. ; Koenig, Andrew S....
Arthritis Research & Therapy. 19 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

6

Discordance between patient and physician assessments of gl..:

Smolen, Josef S. ; Strand, Vibeke ; Koenig, Andrew S....
Arthritis Research & Therapy. 18 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

7

Short-term efficacy of etanercept plus methotrexate vs comb..:

Fleischmann, Roy ; Koenig, Andrew S. ; Szumski, Annette...
Rheumatology. 53 (2014) 11 - p. 1984-1993 , 2014

Link: https://doi.org/10.1093/..

8

Symptomatic Efficacy of Etanercept and Its Effects on Objec..:

Dougados, Maxime ; van der Heijde, Désirée ; Sieper, Joachim...
Arthritis & Rheumatology. 66 (2014) 8 - p. 2091-2102 , 2014

Link: https://doi.org/10.1002/..

9

Induction of response with etanercept–methotrexate therapy ..:

Pavelka, Karel ; Szekanecz, Zoltan ; Damjanov, Nemanja...
Clinical Rheumatology. 32 (2013) 9 - p. 1275-1281 , 2013

Link: https://doi.org/10.1007/..

10

Associations between inflammation, nocturnal back pain and ..:

Hammoudeh, Mohammed ; Zack, Debra J ; Li, Wenzhi..
Journal of International Medical Research. 41 (2013) 4 - p. 1150-1159 , 2013

Link: https://doi.org/10.1177/..

11

Maintenance, reduction, or withdrawal of etanercept after t..:

Smolen, Josef S ; Nash, Peter ; Durez, Patrick...
The Lancet. 381 (2013) 9870 - p. 918-929 , 2013

Link: https://doi.org/10.1016/..

12

Improved health outcomes with Etanercept versus usual DMARD..:

Bae, Sang-Cheol ; Gun, Suk Chyn ; Mok, Chi Chiu...
BMC Musculoskeletal Disorders. 14 (2013) 1 - p. , 2013

Link: https://doi.org/10.1186/..

13

Clinical efficacy and safety of etanercept versus sulfasala..:

Braun, Juergen ; van der Horst-Bruinsma, Irene E. ; Huang, Feng...
Arthritis & Rheumatism. 63 (2011) 6 - p. 1543-1551 , 2011

Link: https://doi.org/10.1002/..

14

Two-year clinical and radiographic results with combination..:

Emery, Paul ; Breedveld, Ferdinand ; van der Heijde, Désirée...
Arthritis & Rheumatism. 62 (2010) 3 - p. 674-682 , 2010

Link: https://doi.org/10.1002/..

15

Long Term Extension Study of Tofacitinib in Refractory Derm..:

Paik, Julie J ; Shneyderman, Matthew ; Gutierrez-Alamillo, Laura...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863430/. , 2022

Link: http://www.ncbi.nlm.nih...